Please login to the form below

Not currently logged in
Email:
Password:

TxCell appoints François Myer as executive chairman

He brings experience from Rhone Poulenc Rorer and Aventis Pharma to the biotech

TxCell Francois MeyerFrench biotech company TxCell has appointed François Meyer as its executive chairman as it completes a strategic realignment around its CAR-Treg research programmes.

In his new role Meyer will head up Valbonne-based TxCell's newly-formed research group, which is made up of Cell Engineering, Pharmacology and Process Development units and comprises of 31 employees.

Meyer brings 35 years of industry experience to his new position, accrued from firms such as Rhone Poulenc Rorer and Aventis Pharma (both now part of Sanofi), where he served as head of research.

As part of the changes Dr Miguel Forte, executive vice president and chief operating officer, will be leaving the company.

Stéphane Boissel, CEO of TxCell, said: “TxCell has now completed its strategic and organizational transformation. I would like to thank all stakeholders, notably Miguel Forte, for their contribution to this rapid, profound turnaround.

“We can now look to the future with great expectations and with one major objective in mind: for TxCell to be the first organization ever to put a CAR-Treg product in clinical development, with the aim of achieving this by 2018.”

22nd December 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

OUTiCO Case Study - Product Launch
POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS!...
An insight into Multi-Channel Account Management
At OUTiCO we often talk about moving away from traditional methods, embracing change, and offering an exceptional outsourcing service, but what does that mean day to day?...
14_ipad_lowres.jpg
Why AI might be the rep’s best friend
When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...

Infographics